# MoldCo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/moldco

- Industry: Healthcare IT
- Headquarters: Boston, US
- Website: www.moldco.com/
- Total disclosed funding: $8M
- Latest round: Seed (Sep 18, 2025)
- Investors on record: 6

## About

Founded in 2023 and based in Boston, US, The Immune Co., doing business as MoldCo, is a provider of an online retail platform that offers household and health products to reduce mycotoxins, bacteria, viruses, and other pollutants to help customers reduce mold-related illness. MoldCo's core offerings include mold-specialized biomarker testing, scientifically supported binders, nasal biofilm disruptors, and peptides to restore metabolic health, eliminate harmful microbes, and mitigate inflammation. The primary end-users of MoldCo’s services are individuals experiencing symptoms related to mold toxicity, such as brain fog, fatigue, and chronic sinus infections. The company offers evidence-based, customized solutions by mold-trained and certified clinicians. IIn September 2025, MoldCo raised USD 8 million in seed funding co-led by new investors Cantos Ventures and Collaborative Fund. Returning investors, Behind Genius Ventures, Bleu Capital, Starship Ventures. New investor AJ2 Fund and other individual investors also participated in the round.

## Funding rounds

- Seed, Sep 18, 2025, $8M — Collaborative Fund, Cantos Ventures, Bleu Capital, Starship Ventures, Behind Genius Ventures, AJ2 Fund

## Investors

- Collaborative Fund (https://capitalatlas.ai/funds/collaborative-fund) — Seed
- Cantos Ventures (https://capitalatlas.ai/funds/cantos-ventures) — Seed
- Bleu Capital (https://capitalatlas.ai/funds/bleu-capital) — Seed
- Starship Ventures (https://capitalatlas.ai/funds/starship-ventures) — Seed
- Behind Genius Ventures (https://capitalatlas.ai/funds/behind-genius-ventures) — Seed
- AJ2 Fund — Seed